Objective-To determine whether fibrinogen and lipid concentrations are risk factors for ischaemic stroke.
Introduction
Many risk factors have been associated with stroke. Case-control and cohort studies have established age, blood pressure, heart disease, atrial fibrillation, transient ischaemic attack, peripheral vascular disease, diabetes mellitus, smoking, cervical arterial bruit, and male sex as risk factors.1 2 A recent prospective study suggested that fibrinogen may be a more powerful predictor of stroke than is blood pressure,3 although the study adjusted only for blood pressure, total cholesterol, and smoking habits and not for other variables that may also be confounders, such as social class. 4 The precise relation between lipids, lipoproteins, and stroke is not clear. The study of metabolic variables in a case-control study is complicated by changes that occur after stroke: fibrinogen concentrations clearly rise5 and total cholesterol concentrations fall. 6 We therefore conducted a case-control study to investigate the relation of fibrinogen and lipoproteins with stroke. We studied transient ischaemic attacks as a surrogate model for ischaemic stroke because such attacks are less likely to affect these metabolic variables.
We also looked at minor ischaemic stroke. Our underlying assumption was that although transient ischaemic attack, minor ischaemic stroke, and major ischaemic stroke are clinically different, they arise from the same underlying arterial disease. We also conducted a case-control comparison of subjects with transient ischaemic attack and controls recruited through their general practitioners, to avoid any bias of hospital referral.
Patients and methods
We studied all patients over the age of 20 who were referred to a neurology clinic or reported to the Oxfordshire community stroke project7 with a transient ischaemic attack or minor ischaemic stroke. The diagnosis was confirmed by one of us (CW), soon after the attacks, and all patients were studied within one year after notification of the episode.
We defined a transient ischaemic attack as an acute loss of focal, cerebral, or ocular function with symptoms lasting less than 24 hours that, after investigation, was assumed to be due to embolic or thrombotic vascular disease. A minor ischaemic stroke was defined as an acute loss of focal cerebral function with symptoms lasting longer than 24 hours but less than seven days that, after investigation, was assumed to be due to embolic or thrombotic vascular disease. We excluded patients with focal epilepsy, migraine, structural brain lesions (such as tumours), local disease of the eye (such as glaucoma), potential structural cardiac source for emboli (such as mitral valve disease), and general medical disorders such as myeloma. Patients who presented with transient ischaemic attack preceded by stroke and those who presented with minor ischaemic stroke preceded by major stroke were also excluded. Computed tomography was used to exclude intracranial haemorrhage in all patients with minor ischaemic strokes and, less importantly, 74% of those with transient ischaemic attacks.
The study was designed to detect a 0 4 g/l difference in fibrinogen concentration between the groups,3 with over 95% power at the 5% level of significance and a ratio of one case to two controls. This power required 101 cases (the approximate number capable of being recruited within two years) and 202 controls. Given an expected 60% response rate among controls asked for blood samples, we asked 105 cases to participate and selected 352 controls. Although we had originally intended to recruit twice as many cases as controls, recruitment of controls was increased to maintain statistical power when early case incidence and control compliance were lower than expected. Control subjects were selected randomly from the age and sex registers of local general practitioners, stratified to give roughly equal proportions in five year age groups and sex to the series, which we predicted from the age and sex distribution of patients with transient ischaemic attack who had been recruited to the Oxfordshire community stroke project. Because of this the age distribution of controls differed slightly from that of cases. In particular, five people in the control group but no cases were aged under 40 . The lipid concentrations in these five controls did not differ substantially from those in the other controls, so they were retained in the study. Age was adjusted for in multivariate analyses (see below).
Consenting cases and controls were seen at home; cases were visited at least four weeks after the attack. Cases and controls were asked about social class, history of vascular disease (ischaemic heart disease, hypertension, diabetes mellitus), history of cigarette smoking, alcohol consumption in past few months, and snoring habits. Blood pressure was recorded with a random zero sphygmomanometer; Korotkoff phase V was used to define diastolic pressure. Height and weight were also measured. Non-fasting blood samples were taken without venestasis during the visit, and the plasma was stored at -280C. quarters to test the linear trend. Data on patients in the study who had been recruited from the Oxfordshire community stroke project with transient ischaemic attack and on all controls were analysed separately, providing a pure community based case-control study of patients whose symptoms had resolved within hours that was free of hospital referral bias.
The aetiological fraction (excess risk or population attributable risk), defined as the proportion of all cases of stroke in the target population attributable to high lipid or fibrinogen concentrations was calculated by standard formulas." The exposure category was assigned by using concentrations above. the median values for the control group. Provided that the association between the disease and the variable is causal, it can be interpreted as the proportion of transient ischaemic attacks or minor ischaemic strokes in the target population that would not have occurred had all subjects had values below the median.
Results
Among the 105 cases, 49 subjects with transient ischaemic attacks and 14 with minor ischaemic strokes had been recruited from the community and 41 with transient ischaemic attack and 1 with minor ischaemic stroke had been recruited from a neurology clinic. Blood samples were available from all but one of the cases (in a subject with a transient ischaemic attack recruited from hospital). Three hundred and fifty two controls were selected for the study from general practitioners' lists (excluding those who had died or moved away but remained on the general practitioners' registers). Ten were excluded because they had had a stroke, leaving 342 eligible controls. Forty two refused interview or were vetted as unsuitable by the responsible general practitioner, usually because of ill health or psychological factors. This left 300 consenting controls, 241 ofwhom provided blood samples, although all assays could not be performed for each control because of breakages and inadequate plasma volumes. The mean (SD) ages were 67-7 (10-8) years for cases and 67 6 (11 1) years for controls, and there were 68 (65%) and 161 (67%) men among cases and controls, respectively. The mean (SD) age of the controls who did not provide blood was 70 3 (10 7); 42 of these controls were men. Table I shows the mean values and differences between patients who had transient ischaemic attack or minor ischaemic stroke and the controls for fibrinogen, total cholesterol, low density lipoprotein, and high density lipoprotein cholesterol concentrations. Table  II gives the odds ratios and 95% confidence intervals when these continuous variables were dichotomised at the arbitrary level of the rounded median of the control group and adjusted odds ratios after multivariate adjustment for all other possible confounding variables assessed. Fibrinogen, total cholesterol, and low density lipoprotein cholesterol concentrations were significantly higher in cases than in controls; high density lipo- protein cholesterol concentration was significantly lower in cases. Dichotomising these variables at the median value for controls gave significant unadjusted odds ratios in each case. After adjusting for possible confounders the odds ratios became non-significant except that for high density lipoprotein (p=0.002). Subset analysis of those cases recruited from the community with transient ischaemic attack and of controls showed results comparable with those obtained in the overall analysis (Table I ). The mean differences in the variables were similar and, though confidence intervals were wider, the significance of the mean differences was little changed except for that for high density lipoprotein cholesterol. High density lipoprotein cholesterol concentration was lower in the cases than in the controls by a degree almost identical with that in the main analysis, but the difference was only just significant (p=005). Table IV summarises the results for other variables assessed in the study. A history of ischaemic heart disease and a history of hypertension were significant in univariate analysis. Packed cell volume dichotomised at 045 was also significant, but the difference in means between cases and controls was small (06%) and not significant when compared with Student's t test (p=02, 95% confidence interval -04% to 1-6%). Body mass index was not a significant risk factor.
Discussion
We found higher concentrations of fibrinogen and total cholesterol and lower concentrations of high density lipoprotein cholesterol to be independent Our study is in overall agreement with the results of the two small case-control studies relating fibrinogen to transient ischaemic attack.'8' One of the studies, however, used a control group that excluded subjects with any history of cardiovascular disease'8 and in the other the age distributions of the cases and of the controls were different." Furthermore, no adjustment was made for confounding. The control subjects selected for the study that were thought unsuitable by their general practitioners were probably more ill than were those we studied. They were also more likely to have non-vascular disease, especially cancer. Cancer is known to increase fibrinogen concentrations,'9 thus bias from this source of non-response cannot be discounted. As the age match between cases and controls was so close despite the fact that age was not matched individually serious bias probably did not occur because of controls' refusal to participate.
The significant dose-response relation with fibrinogen, after adjustment for confounders, supports the existence ofa true positive association. Though difficult to completely disprove, little evidence exists to support the notion that fibrinogen concentration increases after a transient ischaemic attack or minor ischaemic stroke.2" Moreover, the differences in mean fibrinogen concentrations between cases and controls in this study and the first prospective study to identify fibrinogen as a risk factor for stroke8 were similar: 043 g/l (this study) and 040 g/13 respectively. The Framingham study2' found a significant association between increasing fibrinogen concentration and risk of stroke in men but not in women. In our study, however, although female controls had significantly higher fibrinogen concentrations than did male controls, there was no significant difference in the odds ratios for fibrinogen between men and women (p>O 1).
Our results for total cholesterol are supported by a prospective study that found total cholesterol concentration to be significantly higher, but only univariately, in those developing transient ischaemic attack than in controls." The only other aetiological study of lipids and transient ischaemic attack found that total cholesterol concentrations were no higher in cases than in age and sex matched controls."' Though 
